Daclizumab (Zenapax®)
Used in combination with standard immunosuppressive agents. It is the first genetically engineered drug to reduce the risk of organ rejection in kidney transplant patients without increasing overall side effects.
How to take: Read the rest of this entry…
Daclizumab is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids. The recommended dose for Daclizumab is 1.0 mg/kg. The calculated volume of Daclizumab should be mixed with 50 mL of sterile 0.9% sodium chloride solution and administered via a peripheral or central vein over a 15-minute period.